Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28753384

Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Oct 1
First author
Oudard S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Oct 1;35(28):3175-3177. doi: 10.1200/JCO.2017.74.7931.
    note
    Source null
    related pmid
    28809609
    relationship
    Comment in
  2. citation
    J Urol. 2018 Apr;199(4):893-894. doi: 10.1016/j.juro.2018.01.031.
    note
    Source null
    related pmid
    29642359
    relationship
    Comment in

Authors and identifiers

  1. name
    Oudard S
    type
    Author
  2. name
    Fizazi K
    type
    Author
  3. name
    Sengeløv L
    type
    Author
  4. name
    Daugaard G
    type
    Author
  5. name
    Saad F
    type
    Author
  6. name
    Hansen S
    type
    Author
  7. name
    Hjälm-Eriksson M
    type
    Author
  8. name
    Jassem J
    type
    Author
  9. name
    Thiery-Vuillemin A
    type
    Author
  10. name
    Caffo O
    type
    Author
  11. name
    Castellano D
    type
    Author
  12. name
    Mainwaring PN
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Oudard S
    type
    Author
  2. name
    Fizazi K
    type
    Author
  3. name
    Sengeløv L
    type
    Author
  4. name
    Daugaard G
    type
    Author
  5. name
    Saad F
    type
    Author
  6. name
    Hansen S
    type
    Author
  7. name
    Hjälm-Eriksson M
    type
    Author
  8. name
    Jassem J
    type
    Author
  9. name
    Thiery-Vuillemin A
    type
    Author
  10. name
    Caffo O
    type
    Author
  11. name
    Castellano D
    type
    Author
  12. name
    Mainwaring PN
    type
    Author
bibliography ids
  1. nci-bib-f6e7012e177b43242315c03e
book metadata
content sha256
cc3e4314529ba5adb963121b6d3756b3792ed536e91368f5e4563e41599d400e
document type
citation
dois
  1. 10.1200/JCO.2016.72.1068
electronic publication date
display
2017 Jul 28
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28753384
immutable id
pubmed:28753384@cc3e4314529ba5adb963121b6d3756b3792ed536e91368f5e4563e41599d400e
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
28
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3189-3197
volume
35
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Oct 1;35(28):3175-3177. doi: 10.1200/JCO.2017.74.7931.
    note
    Source null
    related pmid
    28809609
    relationship
    Comment in
  2. citation
    J Urol. 2018 Apr;199(4):893-894. doi: 10.1016/j.juro.2018.01.031.
    note
    Source null
    related pmid
    29642359
    relationship
    Comment in
outcomes validated
false
pmid
28753384
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
a4e16c4abae353e0a5d7d9d4e2c352c985f00bb7be9805622e9a5a0ff3f18cb7
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Oct 1
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28753384/
title
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA.

Preserved source evidence · Not medical advice